Cargando…
Enhancement of drug sensitivity of human malignancies by epidermal growth factor.
We have previously shown that epidermal growth factor (EGF) enhances the in vitro and in vivo sensitivity of human ovarian carcinoma 2008 cells to cisplatin. EGF was found to enhance selectively the in vivo toxicity of cisplatin to 2008 cell xenografts without altering the toxicity of cisplatin to n...
Autores principales: | Kröning, R., Jones, J. A., Hom, D. K., Chuang, C. C., Sanga, R., Los, G., Howell, S. B., Christen, R. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033868/ https://www.ncbi.nlm.nih.gov/pubmed/7669570 |
Ejemplares similares
-
Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line.
por: Isonishi, S., et al.
Publicado: (1994) -
Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo.
por: Gately, D. P., et al.
Publicado: (1994) -
Enhancement of epidermal regeneration by biosynthetic epidermal growth factor
Publicado: (1986) -
Epidermal and transforming growth factor alpha in patients with breast tumours.
por: Gregory, H., et al.
Publicado: (1989) -
Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.
por: Barker, S., et al.
Publicado: (1989)